Classification of Neurocognition in Japanese Patients with Schizophrenia: A Cluster Analysis

被引:0
|
作者
Kurebayashi, Yusuke [1 ]
Otaki, Junichi [2 ]
机构
[1] Kio Univ, Fac Nursing, Nara 6350832, Japan
[2] Kyorin Univ, Tokyo 1818611, Japan
关键词
EFFICACY;
D O I
10.1155/2024/3920137
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objectives. Cognitive functions in almost all domains are lower in patients with schizophrenia than those in healthy controls, with the severity of impairment differing between domains. Treatments are being developed to improve cognitive impairment in patients with schizophrenia. However, the pattern of cognitive impairment must be clarified to facilitate treatment. Therefore, this study aimed to classify the patterns of cognitive impairment in individuals and provide treatment suggestions. Methods. Patients with schizophrenia were recruited from two psychiatric hospitals in Japan. Demographic and psychopathological symptoms were assessed using the Positive and Negative Symptoms Scale for Schizophrenia and neurocognitive functions, using the CogHealth battery. The following domains were assessed: processing speed, visual attention, working memory, visual learning, and spatial attention. The scores were standardised and assigned as the same-aged average score. Hierarchical cluster analysis using Ward's method was performed based on CogHealth scores. Subsequently, one-way analysis of variance (ANOVA) and Tukey's multiple comparisons were performed to compare the variables in each cluster. Results. In total, 133 participants were classified into four clusters: Cluster 1 (n = 16), with severe cognitive impairment and psychiatric symptoms and the longest stay; Cluster 2 (n = 44), with moderate cognitive impairment and psychiatric symptoms; Cluster 3 (n = 42), with preserved cognitive function, except for spatial perception, and mild psychiatric symptoms; and Cluster 4 (n = 31), with only memory and spatial perception impairment and mild psychiatric symptoms. Implications. The clusters indicate that impairment may occur in all or selective domains. Selective domain impairments may be in spatial perception or in spatial perception and memory. Therefore, it is recommended that treatments for cognitive dysfunction are developed into four subsets considering an individual's cognitive features.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Neurocognition in Early-Onset Schizophrenia
    Frangou, Sophia
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2013, 22 (04) : 715 - +
  • [42] AKT1 and neurocognition in schizophrenia
    Pinheiro, Andrea Poyastro
    Keefe, Richard S. E.
    Skelly, Tara
    Olarte, Megan
    Leviel, Keren
    Lange, Leslie A.
    Lange, Ethan M.
    Stroup, T. Scott
    Lieberman, Jeffrey
    Sullivan, Patrick F.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (02): : 169 - 177
  • [43] SMOKING AND NEUROCOGNITION IN SCHIZOPHRENIA AND BIPOLAR DISORDER
    Merino, T.
    Balanza, V.
    Selva, G.
    Salazar, J.
    Correa, P.
    Fuentes, I.
    Tabares, R.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [44] Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients
    Swerdlow, Neal R.
    Bhakta, Savita G.
    Talledo, Jo A.
    Franz, Daniel M.
    Hughes, Erica L.
    Rana, Brinda K.
    Light, Gregory A.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (04) : 708 - 717
  • [45] Epigenetic clock analysis of blood samples from Japanese schizophrenia patients
    Okazaki, Satoshi
    Otsuka, Ikuo
    Numata, Shusuke
    Horai, Tadasu
    Mouri, Kentaro
    Boku, Shuken
    Ohmori, Tetsuro
    Sora, Ichiro
    Hishimoto, Akitoyo
    NPJ SCHIZOPHRENIA, 2019, 5 (1):
  • [46] Schizotypal disorder and schizophrenia: A profile analysis of neuropsychological functioning in Japanese patients
    Matsui, Mie
    Yuuki, Hiromi
    Kato, Kanade
    Takeuchi, Ai
    Nishiyama, Shimako
    Bilker, Warren B.
    Kurachi, Masayoshi
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2007, 13 (04) : 672 - 682
  • [47] Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis
    Stephane Cheung
    Yukinobu Hamuro
    Jörg Mahlich
    Takanobu Nakahara
    Rosarin Sruamsiri
    Sunny Tsukazawa
    Clinical Drug Investigation, 2017, 37 : 559 - 569
  • [48] Epigenetic clock analysis of blood samples from Japanese schizophrenia patients
    Satoshi Okazaki
    Ikuo Otsuka
    Shusuke Numata
    Tadasu Horai
    Kentaro Mouri
    Shuken Boku
    Tetsuro Ohmori
    Ichiro Sora
    Akitoyo Hishimoto
    npj Schizophrenia, 5
  • [49] Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis
    Cheung, Stephane
    Hamuro, Yukinobu
    Mahlich, Joerg
    Nakahara, Takanobu
    Sruamsiri, Rosarin
    Tsukazawa, Sunny
    CLINICAL DRUG INVESTIGATION, 2017, 37 (06) : 559 - 569
  • [50] Identification of subtypes of Chinese schizophrenia patients before discharge: A cluster analysis
    Liu, S.
    Li, Z.
    EUROPEAN PSYCHIATRY, 2016, 33 : S257 - S257